7 November 2026 · Economy
NPPA caps trade margin on 137 anti-cancer medicines at 30%
The National Pharmaceutical Pricing Authority capped trade margins on 137 non-scheduled anti-cancer medicines at 30% of the maximum retail price, with revised prices taking effect on November 9, 2026. The measure curbs excessive markups along the pharmaceutical supply chain to reduce patient costs. The revised MRPs are calculated from average distributor prices of March 2026. The move brings down drug prices by an average of 20% to 70%, with estimated annual consumer savings exceeding ₹3,500 crore.
Facts to remember
- 1The National Pharmaceutical Pricing Authority capped trade margins on 137 non-scheduled anti-cancer medicines at 30% of the maximum retail price.
- 2The revised prices of the 137 anti-cancer medicines take effect on November 9, 2026.
- 3The new maximum retail price of each medicine under the order is calculated using its average distributor price of March 2026.
Test yourself
Q1.At what percentage of the maximum retail price did the NPPA cap the trade margin on the selected non-scheduled oncology medicines?
Q2.From which date do the revised prices under the NPPA trade margin capping order take effect?
Q3.Which month of 2026 was designated as the baseline period for calculating the new maximum retail price of the capped medicines?
Sources: PIB (English) · AIR News (newsonair.gov.in) · PIB (English) · AIR News (newsonair.gov.in)
